Skip to main content
Erschienen in: Acta Diabetologica 1/2010

01.12.2010 | Original Article

Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia

verfasst von: Christian Schaefer, Tanja Biermann, Malte Schroeder, Ina Fuhrhop, Andreas Niemeier, Wolfgang Rüther, Petra Algenstaedt, Nils Hansen-Algenstaedt

Erschienen in: Acta Diabetologica | Sonderheft 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Microvascular complications are an important cause of morbidity in diabetic patients and can be detected in a significant number of patients at the time of diabetes diagnosis. However, little is known about the alterations in the microvasculature previous to the clinical manifestation of diabetes mellitus type 2. To obtain more insights into the early microvascular deterioration resulting from prediabetes, morphological and functional microvascular parameters were monitored using intravital fluorescence microscopy through a dorsal skin-fold chamber preparation in the uncoupling promotor-driven diphtheria toxin A chain (UCP1/DTA) mice. At the age of 12 weeks, the UCP1/DTA-mice were characterized by impaired glucose tolerance with concurrent unchanged fasting glucose, as well as dyslipidemia, hyperinsulinemia, hypertension and obesity. Prediabetic mice displayed combined hypertriglyceridemia and hypercholesterinemia. Associated with these prediabetic metabolic alterations, we demonstrate that microvascular density showed a dramatic decrease due to a reduction in perfused small vessels. A reduction in vascular density combined with unaltered blood flow in single vessels resulted in impaired tissue perfusion. Endothelial dysfunction with subsequently increased microvascular permeability and leukocyte–endothelium interactions were found. Our results of profound microvascular alterations at stages of normal fasting glucose underline the importance of early screening for prediabetes and associated microvascular complications.
Literatur
1.
Zurück zum Zitat Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW (1998) Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (niddm). Muscle Nerve 21:72–80CrossRefPubMed Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW (1998) Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (niddm). Muscle Nerve 21:72–80CrossRefPubMed
2.
Zurück zum Zitat Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of niddm occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819CrossRefPubMed Harris MI, Klein R, Welborn TA, Knuiman MW (1992) Onset of niddm occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 15:815–819CrossRefPubMed
3.
Zurück zum Zitat Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552–557CrossRefPubMed Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M (1994) Microalbuminuria precedes the development of NIDDM. Diabetes 43:552–557CrossRefPubMed
4.
Zurück zum Zitat Bavenholm PN, Efendic S (2006) Postprandial hyperglycaemia and vascular damage—the benefits of acarbose. Diab Vasc Dis Res 3:72–79CrossRefPubMed Bavenholm PN, Efendic S (2006) Postprandial hyperglycaemia and vascular damage—the benefits of acarbose. Diab Vasc Dis Res 3:72–79CrossRefPubMed
5.
Zurück zum Zitat Singleton JR, Smith AG, Russell JW, Feldman EL (2003) Microvascular complications of impaired glucose tolerance. Diabetes 52:2867–2873CrossRefPubMed Singleton JR, Smith AG, Russell JW, Feldman EL (2003) Microvascular complications of impaired glucose tolerance. Diabetes 52:2867–2873CrossRefPubMed
6.
Zurück zum Zitat Leiter LA (2005) The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabet Res Clin Pract 68(Suppl 2):S3–S14CrossRef Leiter LA (2005) The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering? Diabet Res Clin Pract 68(Suppl 2):S3–S14CrossRef
7.
Zurück zum Zitat Oda H, Keane WF (1999) Recent advances in statins and the kidney. Kidney Int 71:S2–S5CrossRef Oda H, Keane WF (1999) Recent advances in statins and the kidney. Kidney Int 71:S2–S5CrossRef
8.
Zurück zum Zitat Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D (1996) Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) report 22. Arch Ophthalmol 114:1079–1084PubMed Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D (1996) Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) report 22. Arch Ophthalmol 114:1079–1084PubMed
9.
Zurück zum Zitat Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA (2004) A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 53:2883–2892CrossRefPubMed Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA (2004) A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 53:2883–2892CrossRefPubMed
10.
Zurück zum Zitat Glucose Tolerance Mortality (1999) Comparison of who and American diabetes association diagnostic criteria. The decode study group. European diabetes epidemiology group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354:617–621CrossRef Glucose Tolerance Mortality (1999) Comparison of who and American diabetes association diagnostic criteria. The decode study group. European diabetes epidemiology group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354:617–621CrossRef
11.
Zurück zum Zitat Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the stop-NIDDM trial. JAMA 290:486–494CrossRefPubMed Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the stop-NIDDM trial. JAMA 290:486–494CrossRefPubMed
12.
Zurück zum Zitat Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K (2006) Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 13:555–561CrossRefPubMed Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K (2006) Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil 13:555–561CrossRefPubMed
13.
Zurück zum Zitat Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A (1999) Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48:1856–1862CrossRefPubMed Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A (1999) Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 48:1856–1862CrossRefPubMed
14.
Zurück zum Zitat Kempf K, Rose B, Herder C, Haastert B, Fusbahn-Laufenburg A, Reifferscheid A, Scherbaum WA, Kolb H, Martin S (2007) The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J Mol Med (Berlin, Germany) 85:389–396 Kempf K, Rose B, Herder C, Haastert B, Fusbahn-Laufenburg A, Reifferscheid A, Scherbaum WA, Kolb H, Martin S (2007) The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression. J Mol Med (Berlin, Germany) 85:389–396
15.
Zurück zum Zitat Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146–154CrossRefPubMed Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146–154CrossRefPubMed
16.
Zurück zum Zitat Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, Kearney MT (2007) Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab 293:E1311–E1319CrossRefPubMed Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, Kearney MT (2007) Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab 293:E1311–E1319CrossRefPubMed
17.
Zurück zum Zitat Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701–710CrossRefPubMed Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Esposito K, Giugliano D (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701–710CrossRefPubMed
18.
Zurück zum Zitat Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K, Giugliano D (2005) Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111:2518–2524CrossRefPubMed Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K, Giugliano D (2005) Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 111:2518–2524CrossRefPubMed
19.
Zurück zum Zitat Algenstaedt P, Schaefer C, Biermann T, Hamann A, Schwarzloh B, Greten H, Ruther W, Hansen-Algenstaedt N (2003) Microvascular alterations in diabetic mice correlate with level of hyperglycemia. Diabetes 52:542–549CrossRefPubMed Algenstaedt P, Schaefer C, Biermann T, Hamann A, Schwarzloh B, Greten H, Ruther W, Hansen-Algenstaedt N (2003) Microvascular alterations in diabetic mice correlate with level of hyperglycemia. Diabetes 52:542–549CrossRefPubMed
20.
Zurück zum Zitat Cheung AT, Perez RV, Chen PC (1999) Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: a computer-assisted intravital microscopy study on the conjunctival microcirculation. Transplantation 68:927–932CrossRefPubMed Cheung AT, Perez RV, Chen PC (1999) Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: a computer-assisted intravital microscopy study on the conjunctival microcirculation. Transplantation 68:927–932CrossRefPubMed
21.
Zurück zum Zitat Panes J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P, Granger DN (1996) Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93:161–167PubMed Panes J, Kurose I, Rodriguez-Vaca D, Anderson DC, Miyasaka M, Tso P, Granger DN (1996) Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation 93:161–167PubMed
22.
Zurück zum Zitat Bollinger A, Frey J, Jager K, Furrer J, Seglias J, Siegenthaler W (1982) Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med 307:1305–1310CrossRefPubMed Bollinger A, Frey J, Jager K, Furrer J, Seglias J, Siegenthaler W (1982) Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med 307:1305–1310CrossRefPubMed
23.
Zurück zum Zitat Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740–742CrossRefPubMed Lowell BB, S-Susulic V, Hamann A, Lawitts JA, Himms-Hagen J, Boyer BB, Kozak LP, Flier JS (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740–742CrossRefPubMed
24.
Zurück zum Zitat Hamann A, Flier JS, Lowell BB (1996) Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137:21–29CrossRefPubMed Hamann A, Flier JS, Lowell BB (1996) Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137:21–29CrossRefPubMed
25.
Zurück zum Zitat Cittadini A, Mantzoros CS, Hampton TG, Travers KE, Katz SE, Morgan JP, Flier JS, Douglas PS (1999) Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity. Circulation 100:2177–2183PubMed Cittadini A, Mantzoros CS, Hampton TG, Travers KE, Katz SE, Morgan JP, Flier JS, Douglas PS (1999) Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity. Circulation 100:2177–2183PubMed
26.
Zurück zum Zitat Klaus S, Munzberg H, Truloff C, Heldmaier G (1998) Physiology of transgenic mice with brown fat ablation: obesity is due to lowered body temperature. Am J Physiol 274:R287–R293PubMed Klaus S, Munzberg H, Truloff C, Heldmaier G (1998) Physiology of transgenic mice with brown fat ablation: obesity is due to lowered body temperature. Am J Physiol 274:R287–R293PubMed
27.
Zurück zum Zitat Ragozin S, Niemeier A, Laatsch A, Loeffler B, Merkel M, Beisiegel U, Heeren J (2005) Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice. Arterioscler Thromb Vasc Biol 25:1433–1438CrossRefPubMed Ragozin S, Niemeier A, Laatsch A, Loeffler B, Merkel M, Beisiegel U, Heeren J (2005) Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice. Arterioscler Thromb Vasc Biol 25:1433–1438CrossRefPubMed
28.
Zurück zum Zitat Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281:934–944CrossRefPubMed Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M, Kersten S (2006) The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281:934–944CrossRefPubMed
29.
Zurück zum Zitat Lipowsky HH, Zweifach BW (1978) Application of the “Two-slit” photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 15:93–101CrossRefPubMed Lipowsky HH, Zweifach BW (1978) Application of the “Two-slit” photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 15:93–101CrossRefPubMed
30.
Zurück zum Zitat Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54:3352–3356PubMed Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK (1994) Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54:3352–3356PubMed
31.
Zurück zum Zitat Brizel DM, Klitzman B, Cook JM, Edwards J, Rosner G, Dewhirst MW (1993) A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys 25:269–276CrossRefPubMed Brizel DM, Klitzman B, Cook JM, Edwards J, Rosner G, Dewhirst MW (1993) A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys 25:269–276CrossRefPubMed
32.
Zurück zum Zitat Fukumura D, Salehi HA, Witwer B, Tuma RF, Melder RJ, Jain RK (1995) Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res 55:4824–4829PubMed Fukumura D, Salehi HA, Witwer B, Tuma RF, Melder RJ, Jain RK (1995) Tumor necrosis factor alpha-induced leukocyte adhesion in normal and tumor vessels: effect of tumor type, transplantation site, and host strain. Cancer Res 55:4824–4829PubMed
33.
Zurück zum Zitat (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
34.
35.
Zurück zum Zitat Antonetti DA, Lieth E, Barber AJ, Gardner TW (1999) Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 14:240–248CrossRefPubMed Antonetti DA, Lieth E, Barber AJ, Gardner TW (1999) Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol 14:240–248CrossRefPubMed
36.
Zurück zum Zitat Scalia R, Gong Y, Berzins B, Zhao LJ, Sharma K (2007) Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain. Diabetes 56:1842–1849CrossRefPubMed Scalia R, Gong Y, Berzins B, Zhao LJ, Sharma K (2007) Hyperglycemia is a major determinant of albumin permeability in diabetic microcirculation: the role of mu-calpain. Diabetes 56:1842–1849CrossRefPubMed
37.
Zurück zum Zitat Bonnardel-Phu E, Wautier JL, Schmidt AM, Avila C, Vicaut E (1999) Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48:2052–2058CrossRefPubMed Bonnardel-Phu E, Wautier JL, Schmidt AM, Avila C, Vicaut E (1999) Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo. Diabetes 48:2052–2058CrossRefPubMed
38.
Zurück zum Zitat Tapp RJ, Zimmet PZ, Harper CA, de Courten MP, McCarty DJ, Balkau B, Taylor HR, Welborn TA, Shaw JE (2006) Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract 73:315–321CrossRefPubMed Tapp RJ, Zimmet PZ, Harper CA, de Courten MP, McCarty DJ, Balkau B, Taylor HR, Welborn TA, Shaw JE (2006) Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract 73:315–321CrossRefPubMed
39.
Zurück zum Zitat Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 96:10836–10841CrossRefPubMed Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 96:10836–10841CrossRefPubMed
40.
Zurück zum Zitat Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250:H822–H827PubMed Rubanyi GM, Vanhoutte PM (1986) Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250:H822–H827PubMed
41.
Zurück zum Zitat Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G (1998) Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a nf-kb-dependent fashion. J Clin Invest 101:1905–1915CrossRefPubMed Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G (1998) Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a nf-kb-dependent fashion. J Clin Invest 101:1905–1915CrossRefPubMed
42.
Zurück zum Zitat Huang PH, Sata M, Nishimatsu H, Sumi M, Hirata Y, Nagai R (2008) Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Biomed Pharmacother 62:46–52CrossRefPubMed Huang PH, Sata M, Nishimatsu H, Sumi M, Hirata Y, Nagai R (2008) Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice. Biomed Pharmacother 62:46–52CrossRefPubMed
43.
Zurück zum Zitat Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH (2007) In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF) -activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 56:656–665CrossRefPubMed Li Y, Hazarika S, Xie D, Pippen AM, Kontos CD, Annex BH (2007) In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF) -activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 56:656–665CrossRefPubMed
44.
Zurück zum Zitat Kampfer H, Pfeilschifter J, Frank S (2001) Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 81:361–373PubMed Kampfer H, Pfeilschifter J, Frank S (2001) Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 81:361–373PubMed
45.
Zurück zum Zitat Schaefer C, Krause M, Fuhrhop I, Schroeder M, Algenstaedt P, Fiedler W, Ruther W, Hansen-Algenstaedt N (2008) Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo. Leukemia 22:59–65CrossRefPubMed Schaefer C, Krause M, Fuhrhop I, Schroeder M, Algenstaedt P, Fiedler W, Ruther W, Hansen-Algenstaedt N (2008) Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo. Leukemia 22:59–65CrossRefPubMed
46.
Zurück zum Zitat Dewhirst MW, Ong ET, Braun RD, Smith B, Klitzman B, Evans SM, Wilson D (1999) Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer 79:1717–1722CrossRefPubMed Dewhirst MW, Ong ET, Braun RD, Smith B, Klitzman B, Evans SM, Wilson D (1999) Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer 79:1717–1722CrossRefPubMed
Metadaten
Titel
Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia
verfasst von
Christian Schaefer
Tanja Biermann
Malte Schroeder
Ina Fuhrhop
Andreas Niemeier
Wolfgang Rüther
Petra Algenstaedt
Nils Hansen-Algenstaedt
Publikationsdatum
01.12.2010
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe Sonderheft 1/2010
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0114-7

Weitere Artikel der Sonderheft 1/2010

Acta Diabetologica 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.